GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX)
February 27, 2025 4:05 PM ESTRaymond James analyst Aaron Kessler reiterated a Strong Buy rating and $9.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX).
The analyst comments "All in all, it was a solid quarter, and we expect a more stable cadence of expectations/earnings... More
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi
February 27, 2025 3:15 PM ESTCiti analyst Daniel Grosslight raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.75 (from $6.25) while maintaining a Buy rating.
The analyst comments "After a couple quarters of excess volatility, GDRXs 4Q results should be a bit of a reprieve for... More
